AB Science S.A. (EPA:AB)
1.220
-0.026 (-2.09%)
At close: Mar 13, 2026
AB Science Market Cap
AB Science has a market cap or net worth of €89 million as of March 13, 2026. Its market cap has increased by 1.79% in one year.
Market Cap
89.00M
Enterprise Value
103.04M
Revenue
1.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.22
Market Cap Chart
Since April 26, 2010, AB Science's market cap has decreased from 381.93M to 89.00M, a decrease of -76.70%. That is a compound annual growth rate of -8.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 89.00M | -20.57% |
| Dec 31, 2025 | 112.05M | 94.70% |
| Dec 31, 2024 | 57.55M | -68.19% |
| Dec 29, 2023 | 180.92M | -45.55% |
| Dec 30, 2022 | 332.25M | -40.91% |
| Dec 31, 2021 | 562.31M | -37.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 97.36B |
| Sanofi | 92.40B |
| Sartorius Stedim Biotech | 15.63B |
| Ipsen | 12.59B |
| Euroapi | 121.97M |
| Innate Pharma | 119.22M |
| Adocia | 118.93M |
| ABIONYX Pharma | 118.53M |